Načítá se...
The FDA’s Experience with Emerging Genomics Technologies—Past, Present, and Future
The rapid advancement of emerging genomics technologies and their application for assessing safety and efficacy of FDA-regulated products require a high standard of reliability and robustness supporting regulatory decision-making in the FDA. To facilitate the regulatory application, the FDA implemen...
Uloženo v:
| Vydáno v: | AAPS J |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4973466/ https://ncbi.nlm.nih.gov/pubmed/27116022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-016-9917-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|